tiprankstipranks
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market

Actuate Therapeutics, Inc. (ACTU) Similar Stocks

Compare
7 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Actuate Therapeutics, Inc.
$8.81
Karyopharm Therapeutics
$0.62
$88.32M
-52.15%
4 Buy
0 Hold
0 Sell
Strong Buy
Sorrento Therapeutics
$0.01
$275.64K
-50.00%
FibroGen
$0.50
$51.29M
-81.69%
1 Buy
0 Hold
0 Sell
Moderate Buy
Blueprint Medicines
$104.00
$7.30B
34.12%
9 Buy
4 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
ACTU
Actuate Therapeutics, Inc.
8.75
-0.40
-4.37%
KPTI
Karyopharm Therapeutics
0.62
-0.68
-52.31%
SRNE
Sorrento Therapeutics
0.01
-0.01
-50.00%
FGEN
FibroGen
0.50
-2.22
-81.62%
BPMC
Blueprint Medicines
104.00
26.46
34.12%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis